Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev
K
K
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Scheithauer
B W
BW
Rodriguez
F J
FJ
Jenkins
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D034961:Antigens, Nuclear / Q000378:metabolism; D001254:Astrocytoma / Q000378:metabolism / Q000401:mortality; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001932:Brain Neoplasms / Q000378:metabolism* / Q000401:mortality*; D002648:Child; D002864:Chromogranins / Q000378:metabolism; D005260:Female; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005909:Glioblastoma / Q000378:metabolism* / Q000401:mortality*; D005910:Glioma / Q000378:metabolism / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000378:metabolism; D016900:Neurofilament Proteins / Q000378:metabolism; D011379:Prognosis; D016019:Survival Analysis; D016708:Synaptophysin / Q000378:metabolism; D055815:Young Adult
D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor; D002864:Chromogranins; D005904:Glial Fibrillary Acidic Protein; D009419:Nerve Tissue Proteins; D016900:Neurofilament Proteins; D016708:Synaptophysin; C506808:neuronal nuclear antigen NeuN, human